iZafe Group ABFRA:M02 -5.06%48 Days Inventory is 279.70 as of Mar. 2026, which is 42% below its 10-year median of 480.77. GuruFocus rates FRA:M02 with a GF Score™ of 48/100 and a GF Value™ of €0.04 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 786 Medical Devices & Instruments companies, iZafe Group AB ranks worse than 74.3% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). iZafe Group AB's Average Total Inventories for the
three
months ended in Mar. 2026 was €0.21 Mil. iZafe Group AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €0.07 Mil.
Hence, iZafe Group AB's Days Inventory for the
three
months ended in Mar. 2026 was 279.70.
The historical rank and industry rank for iZafe Group AB's Days Inventory or its related term are showing as below:
FRA:M02'
s Days Inventory Range Over the Past 10 Years
Min: 133.58 Med: 480.77 Max: 2322.21
Current: 279.75
During the past 13 years, iZafe Group AB's highest Days Inventory was 2322.21. The lowest was 133.58. And the median was 480.77.
FRA:M02's Days Inventory is ranked worse than 74.3% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.86
vs FRA:M02: 279.75
iZafe Group AB's Days Inventory
increased
from Mar. 2025 (254.90) to Mar. 2026 (279.70).
It might indicate that iZafe Group AB's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
iZafe Group AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.33.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
iZafe Group AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.94.
iZafe Group AB (FRA:M02) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
iZafe Group AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
iZafe Group AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
iZafe Group AB Days Inventory Related Terms
iZafe Group AB Days Inventory Historical Data
* Premium members only.
The historical data trend for iZafe Group AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:M02 vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, iZafe Group AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iZafe Group AB Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iZafe Group AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where iZafe Group AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iZafe Group AB (FRA:M02) has a Days Inventory of 279.70 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on iZafe Group AB and its competitors. This is 42% below median its historical median of 480.77. Over the past decade, iZafe Group AB's Days Inventory has ranged from 133.58 to 2,322.21. According to the industry distribution chart, iZafe Group AB ranks #584 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 74.3%.
Is iZafe Group AB's Days Inventory too high?
iZafe Group AB's current Days Inventory of 279.70 is 42% below median its 10-year median of 480.77. Over the past 10 years, this metric has ranged from a low of 133.58 to a high of 2,322.21. The Medical Devices & Instruments industry median Days Inventory is 179.86. iZafe Group AB's value of 279.70 is 55.5% above this industry median. Based on the distribution chart, iZafe Group AB ranks #584 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, iZafe Group AB has a GF Score™ of 48/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iZafe Group AB's Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, iZafe Group AB ranks #584 out of 786 companies for Days Inventory. This places iZafe Group AB in the lower half of its industry. The industry median Days Inventory is 179.86. iZafe Group AB's value of 279.70 is 55.5% above this benchmark. Historically, iZafe Group AB's own Days Inventory has ranged from 133.58 to 2,322.21 over the past decade. While the company's 10-year median is 480.77 vs. the industry median of 179.86, iZafe Group AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.86, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iZafe Group AB's current Days Inventory of 279.70 is 55.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on iZafe Group AB and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iZafe Group AB's current Days Inventory is 279.70, which is 42% below median its own 10-year median of 480.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iZafe Group AB stock overvalued right now?
Based on GuruFocus' analysis, iZafe Group AB (FRA:M02) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.04, compared to a current price of €0.03 — trading 15.5% below its estimated fair value. The current Days Inventory is 279.70, which is 42% below median its 10-year median of 480.77 and 55.5% above the Medical Devices & Instruments industry median of 179.86. iZafe Group AB's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For iZafe Group AB (FRA:M02), the current Days Inventory is 279.70 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iZafe Group AB (FRA:M02) Overvalued in 2026?
Based on GuruFocus' analysis, iZafe Group AB stock appears to be undervalued.
The current stock price of €0.03 is trading 15.5% below its estimated GF Value™ of €0.04.
GuruFocus considers iZafe Group AB to be Modestly Undervalued.
Key valuation signals for FRA:M02:
Days Inventory: 279.70 (42% below median its 10-year median of 480.77)
GF Value™: €0.04 vs. price of €0.03 (15.5% below fair value)
Industry Position: 55.5% above the Medical Devices & Instruments median (#584 of 786)
No single metric tells the full story. See the FRA:M02 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iZafe Group AB is a Developer of a digital medication dispensing system designed to enhance patient safety and reduce medication errors in home healthcare. The company offers a smart medication robot with automated dispensing and remote monitoring, enabling public and private healthcare providers in Sweden, the Nordics, and international markets, improved treatment adherence and reduced caregiver workload.
48GF Score
Get the complete analysis for FRA:M02
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M02 has been successfully added to your 
